Join us for the @AlphaTauMedical KOL Breakfast Event featuring Dr. Michael Zelefsky, Dr. Mark D’Andrea, & Dr. Robert Den who will discuss the science behind Alpha Tau’s therapy (Alpha DaRT radiation technology) & its clinical trial outlook. Register here: https://t.co/ilufqdTFx0
Alpha Tau is happy to announce the Alpha DaRT Investigator Meeting for investigators participating in the US Multicenter Pivotal Study for Skin Cancer will be held in #LasVegas Nevada, February 27-28.
We look forward to seeing our clinical collaborators at the @VenetianVegas.
Alpha Tau Medical Announces the Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®).
For the full announcement, please read : https://t.co/6x3PA5g5B6
#clinicaltrials#cancerresearch#immunotherapy
We are thrilled to announce that the Alpha Tau team will be attending (IN PERSON this year - Finally! ) the ASTRO conference in Chicago !
Come to meet us at our booth #1706 to discuss possible collaborations on our clinical trials.
https://t.co/2pxr7gPH8l
According to #clinicaltrials.gov, as of Sept 2021, there were 10 clinical trials with Alpha DaRT (Radium-224) recruiting and another 3 planned by Alpha Tau. This places Alpha Tau at the forefront of the exciting, emerging field of alpha-emitting #radiation therapy for cancer.
The veterinary research group at Alpha Tau is conducting experiments on pigs, to test applicators being designed for use with Alpha DaRT in human patients with #lungcancer.
A big thanks to @SadoughiAli for helping us!
Alpha Tau is proud to support McMedHacks - online, free workshops on medical image analysis and deep learning in #Python - led by @DrShirinAEnger from @McGillMedPhys. After the workshop, will be a Hackathon for participants.
For info & registration: https://t.co/SYOyiREHCv
In an interview with Gila Tolub from @McKinsey, @uzisofer explains two important lessons he learned from his experience as a healthcare innovator and CEO at Alpha Tau.
Read the entire interview at:
https://t.co/dm9LwRTJfC
Dr. @RobertDen6, Alpha Tau CMO, will speak on Alpha DaRT at ABS annual mtg on Wed, Jun 23 at 2:50 PM EST on 𝑪𝒍𝒊𝒏𝒊𝒄𝒂𝒍 𝑷𝒐𝒔𝒔𝒊𝒃𝒊𝒍𝒊𝒕𝒊𝒆𝒔 𝒇𝒐𝒓 𝑵𝒐𝒗𝒆𝒍 𝑩𝒓𝒂𝒄𝒉𝒚𝒕𝒉𝒆𝒓𝒂𝒑𝒚 𝑪𝒐𝒎𝒃𝒊𝒏𝒂𝒕𝒊𝒐𝒏𝒔 & 𝑺𝒐𝒖𝒓𝒄𝒆𝒔
To register see https://t.co/KGR165SlUh
𝐀𝐥𝐩𝐡𝐚 𝐓𝐚𝐮 𝐢𝐬 #𝐇𝐢𝐫𝐢𝐧𝐠 𝐢𝐧 𝐉��𝐫𝐮𝐬𝐚𝐥𝐞𝐦
The billboard below on the Ayalon highway says, “Alpha Tau is hiring in Jerusalem in the war against cancer”. Come join us! Apply for hi-tech #jobs in Jerusalem, including Alpha Tau at:
https://t.co/k4elzC412G
𝐀𝐥𝐩𝐡𝐚 𝐃𝐚𝐑𝐓 𝐑𝐞𝐜𝐞𝐢𝐯𝐞𝐬 “𝐁𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐃𝐞𝐯𝐢𝐜𝐞 𝐃𝐞𝐬𝐢𝐠𝐧𝐚𝐭𝐢𝐨𝐧” 𝐟𝐫𝐨𝐦 𝐅𝐃𝐀
Alpha Tau CEO @uzisofer is proud to announce that Alpha DaRT has received a Breakthrough Device Designation from the FDA.
Please see
https://t.co/m2tk55lUkT
#Jerusalem is considered the beating heart of Israel’s thriving #Biomed industry. One of its stand-out companies is @AlphaTauMedical, a #medicaldevice that uses nuclear energy to #treatcancer. For more information, please go to: https://t.co/YgMJHnuXiY
https://t.co/m3tt3LXigQ
May is Skin Cancer Awareness Month, and Alpha Tau is excited to get #FDA clearance to expand its clinical trial in skin cancer, now recruiting at #MSK Cancer Center in NYC, to other US sites. New sites will be in community oncology practices. More info at https://t.co/vBz3uGsxkf.